A powerful brand-name drug industry trade organization has asked a federal district judge to block Maryland from enforcing the state’s [...] …
Category: Pharma Industry
Pharmaceutical giant Eli Lilly has significantly escalated its restrictions on access to 340B pricing in the contract pharmacy setting, the [...] …
Drug manufacturer Eli Lilly announced a new round of refunds for Humulin, a brand-name insulin, following a 340B ceiling price [...] …
Fourteen years after the Congressional deadline, the long-anticipated revision to the 340B Administrative Dispute Resolution (ADR) process officially took effect [...] …
Drug manufacturer Novartis uses contradictory, “whiplash-inducing” arguments in its lawsuit challenging Mississippi’s 340B contract pharmacy law, hospital groups told a [...] …
The Delaware House late last week overwhelmingly passed a bill to prohibit drugmaker 340B contract pharmacy restrictions on grantee covered [...] …
A state Senate-endorsed bill that would have prohibited 340B contract pharmacy restrictions in Rhode Island failed to clear the legislature [...] …
French drugmaker Sanofi recently filed suit against federal agencies seeking details from contracts between 340B covered entities and outside pharmacies. [...] …
Federal Judge Presses Drug Industry on Preemption Arguments During Key Hearing on Louisiana 340B Law
A federal judge late last week pressed drug industry attorneys on their claims that Louisiana’s 340B contract pharmacy law oversteps [...] …
Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, is now fully exempting West Virginia covered [...] …